Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) EBIT Margin (2018 - 2025)

Neurogene (NGNE) has disclosed EBIT Margin for 5 consecutive years, with 2608100.0% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, EBIT Margin rose 260432251.0% year-over-year to 2608100.0%, compared with a TTM value of 120135.8% through Sep 2025, up 11455492.0%, and an annual FY2024 reading of 8930.27%, down 20744098.0% over the prior year.
  • EBIT Margin was 2608100.0% for Q2 2025 at Neurogene, up from 32398.75% in the prior quarter.
  • Across five years, EBIT Margin topped out at 2608100.0% in Q2 2025 and bottomed at 3119.44% in Q1 2024.